Logo image of ERA.PA

ERAMET (ERA.PA) Stock Fundamental Analysis

EPA:ERA - Euronext Paris - Matif - FR0000131757 - Common Stock - Currency: EUR

47.8  +0.36 (+0.76%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ERA. ERA was compared to 38 industry peers in the Metals & Mining industry. ERA has a medium profitability rating, but doesn't score so well on its financial health evaluation. ERA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year ERA was profitable.
In the past year ERA has reported a negative cash flow from operations.
ERA had positive earnings in 4 of the past 5 years.
ERA had a positive operating cash flow in 4 of the past 5 years.
ERA.PA Yearly Net Income VS EBIT VS OCF VS FCFERA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

1.2 Ratios

ERA has a Return On Assets (0.22%) which is comparable to the rest of the industry.
ERA has a Return On Equity (0.97%) which is comparable to the rest of the industry.
The Return On Invested Capital of ERA (1.39%) is worse than 65.79% of its industry peers.
ERA had an Average Return On Invested Capital over the past 3 years of 7.61%. This is in line with the industry average of 7.34%.
The last Return On Invested Capital (1.39%) for ERA is well below the 3 year average (7.61%), which needs to be investigated, but indicates that ERA had better years and this may not be a problem.
Industry RankSector Rank
ROA 0.22%
ROE 0.97%
ROIC 1.39%
ROA(3y)4.1%
ROA(5y)1.33%
ROE(3y)16.44%
ROE(5y)-1.91%
ROIC(3y)7.61%
ROIC(5y)8.07%
ERA.PA Yearly ROA, ROE, ROICERA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60 -80

1.3 Margins

ERA has a Profit Margin (0.48%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of ERA has declined.
Looking at the Operating Margin, with a value of 3.27%, ERA is in line with its industry, outperforming 42.11% of the companies in the same industry.
ERA's Operating Margin has declined in the last couple of years.
ERA's Gross Margin of 66.89% is amongst the best of the industry. ERA outperforms 92.11% of its industry peers.
ERA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.27%
PM (TTM) 0.48%
GM 66.89%
OM growth 3Y-46.5%
OM growth 5Y-18.83%
PM growth 3Y-61.12%
PM growth 5YN/A
GM growth 3Y-3.21%
GM growth 5Y23.96%
ERA.PA Yearly Profit, Operating, Gross MarginsERA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ERA is destroying value.
The number of shares outstanding for ERA has been increased compared to 1 year ago.
ERA has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ERA has an improved debt to assets ratio.
ERA.PA Yearly Shares OutstandingERA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ERA.PA Yearly Total Debt VS Total AssetsERA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 1.13, we must say that ERA is in the distress zone and has some risk of bankruptcy.
ERA has a Altman-Z score of 1.13. This is in the lower half of the industry: ERA underperforms 76.32% of its industry peers.
A Debt/Equity ratio of 1.35 is on the high side and indicates that ERA has dependencies on debt financing.
ERA has a Debt to Equity ratio of 1.35. This is amonst the worse of the industry: ERA underperforms 81.58% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF N/A
Altman-Z 1.13
ROIC/WACC0.15
WACC9.12%
ERA.PA Yearly LT Debt VS Equity VS FCFERA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

ERA has a Current Ratio of 1.64. This is a normal value and indicates that ERA is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ERA (1.64) is comparable to the rest of the industry.
A Quick Ratio of 1.17 indicates that ERA should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.17, ERA is in the better half of the industry, outperforming 71.05% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 1.17
ERA.PA Yearly Current Assets VS Current LiabilitesERA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

ERA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -88.47%.
Measured over the past years, ERA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -64.00% on average per year.
The Revenue has decreased by -9.78% in the past year.
ERA shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.39% yearly.
EPS 1Y (TTM)-88.47%
EPS 3Y-64%
EPS 5YN/A
EPS Q2Q%406.32%
Revenue 1Y (TTM)-9.78%
Revenue growth 3Y-7.18%
Revenue growth 5Y-4.39%
Sales Q2Q%-10.08%

3.2 Future

The Earnings Per Share is expected to grow by 31.30% on average over the next years. This is a very strong growth
Based on estimates for the next years, ERA will show a quite strong growth in Revenue. The Revenue will grow by 8.07% on average per year.
EPS Next Y-57.76%
EPS Next 2Y8.24%
EPS Next 3Y31.3%
EPS Next 5YN/A
Revenue Next Year6.94%
Revenue Next 2Y8.77%
Revenue Next 3Y8.07%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ERA.PA Yearly Revenue VS EstimatesERA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
ERA.PA Yearly EPS VS EstimatesERA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 20 30

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 111.16, the valuation of ERA can be described as expensive.
60.53% of the companies in the same industry are cheaper than ERA, based on the Price/Earnings ratio.
ERA's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.82.
A Price/Forward Earnings ratio of 26.97 indicates a quite expensive valuation of ERA.
Based on the Price/Forward Earnings ratio, ERA is valued a bit more expensive than 65.79% of the companies in the same industry.
ERA is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 36.21, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 111.16
Fwd PE 26.97
ERA.PA Price Earnings VS Forward Price EarningsERA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ERA.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.41
ERA.PA Per share dataERA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80 100

4.3 Compensation for Growth

ERA's earnings are expected to grow with 31.30% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.24%
EPS Next 3Y31.3%

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.78%, ERA has a reasonable but not impressive dividend return.
ERA's Dividend Yield is a higher than the industry average which is at 3.11.
Compared to an average S&P500 Dividend Yield of 2.39, ERA has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.78%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
ERA.PA Yearly Dividends per shareERA.PA Yearly Dividends per shareYearly Dividends per share 2019 2022 2023 2024 2025 1 2 3

5.3 Sustainability

307.14% of the earnings are spent on dividend by ERA. This is not a sustainable payout ratio.
DP307.14%
EPS Next 2Y8.24%
EPS Next 3Y31.3%
ERA.PA Yearly Income VS Free CF VS DividendERA.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M
ERA.PA Dividend Payout.ERA.PA Dividend Payout, showing the Payout Ratio.ERA.PA Dividend Payout.PayoutRetained Earnings

ERAMET

EPA:ERA (8/4/2025, 5:26:43 PM)

47.8

+0.36 (+0.76%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)07-30 2025-07-30
Earnings (Next)10-30 2025-10-30
Inst Owners11.85%
Inst Owner ChangeN/A
Ins Owners0.17%
Ins Owner ChangeN/A
Market Cap1.37B
Analysts55
Price Target59.5 (24.48%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.78%
Yearly Dividend1.51
Dividend Growth(5Y)N/A
DP307.14%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.51%
PT rev (3m)-17.65%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.5%
Revenue NY rev (3m)1.07%
Valuation
Industry RankSector Rank
PE 111.16
Fwd PE 26.97
P/S 0.47
P/FCF N/A
P/OCF N/A
P/B 0.95
P/tB 1.37
EV/EBITDA 9.41
EPS(TTM)0.43
EY0.9%
EPS(NY)1.77
Fwd EY3.71%
FCF(TTM)-28.23
FCFYN/A
OCF(TTM)-4.35
OCFYN/A
SpS101.98
BVpS50.1
TBVpS34.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.22%
ROE 0.97%
ROCE 1.92%
ROIC 1.39%
ROICexc 1.7%
ROICexgc 1.9%
OM 3.27%
PM (TTM) 0.48%
GM 66.89%
FCFM N/A
ROA(3y)4.1%
ROA(5y)1.33%
ROE(3y)16.44%
ROE(5y)-1.91%
ROIC(3y)7.61%
ROIC(5y)8.07%
ROICexc(3y)11.46%
ROICexc(5y)11.88%
ROICexgc(3y)13.48%
ROICexgc(5y)14.02%
ROCE(3y)10.76%
ROCE(5y)11.32%
ROICexcg growth 3Y-56.22%
ROICexcg growth 5Y-25.38%
ROICexc growth 3Y-55.33%
ROICexc growth 5Y-24.94%
OM growth 3Y-46.5%
OM growth 5Y-18.83%
PM growth 3Y-61.12%
PM growth 5YN/A
GM growth 3Y-3.21%
GM growth 5Y23.96%
F-Score2
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF N/A
Debt/EBITDA 7.9
Cap/Depr 454.97%
Cap/Sales 23.42%
Interest Coverage 0.56
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.64
Quick Ratio 1.17
Altman-Z 1.13
F-Score2
WACC9.12%
ROIC/WACC0.15
Cap/Depr(3y)260.42%
Cap/Depr(5y)209.27%
Cap/Sales(3y)18.57%
Cap/Sales(5y)15.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-88.47%
EPS 3Y-64%
EPS 5YN/A
EPS Q2Q%406.32%
EPS Next Y-57.76%
EPS Next 2Y8.24%
EPS Next 3Y31.3%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.78%
Revenue growth 3Y-7.18%
Revenue growth 5Y-4.39%
Sales Q2Q%-10.08%
Revenue Next Year6.94%
Revenue Next 2Y8.77%
Revenue Next 3Y8.07%
Revenue Next 5YN/A
EBIT growth 1Y-23.81%
EBIT growth 3Y-50.34%
EBIT growth 5Y-22.39%
EBIT Next Year104.71%
EBIT Next 3Y37.27%
EBIT Next 5YN/A
FCF growth 1Y-61.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-161.27%
OCF growth 3YN/A
OCF growth 5YN/A